Optimizing Cough Rehabilitation Through Combined Cough Skill Training and Transcutaneous Spinal Cord Stimulation (Optimizing Cou)
The goal of this clinical trial is to evaluate the effects of combining cough training with low-level electrical stimulation to the neck (tsDCS) in healthy adults and adults with neurological diseases. The main questions it aims to answer are:
- Is using tsDCS during cough training safe, tolerable, and acceptable to participants?
- What tsDCS settings are most effective for pairing with cough training? Researchers will compare sham stimulation with active tsDCS to see if tsDCS enhances cough gains. Before and after each testing session, participants will complete breathing, coughing, and respiratory-strength training.
Descripción general del estudio
Estado
Estado
Condiciones
Condiciones
Intervención / Tratamiento
Intervención / Tratamiento
Descripción detallada
Study Purpose and Background People with neurodegenerative diseases frequently experience reduced cough function (hypotussia) and swallowing difficulties (dysphagia), which negatively impact quality of life and increase the risk of pneumonia, a leading cause of death in these populations. While behavioral exercises like cough training can help improve airway protection, people with these diseases often struggle to perform them with the high intensity required to trigger lasting brain and nerve adaptation (neuroplasticity).
To overcome this limitation, this pilot study investigates a novel, non-invasive combinatorial approach: pairing Cough Skill Training (CST) with transcutaneous spinal direct current stimulation (tsDCS) applied to the neck. The theory is that spinal stimulation enhances communication between the brain and muscles, optimizing the outcomes of training. Because this combined intervention has not been tested before, this initial research aims to establish its overall feasibility and compare different stimulation settings in healthy adults before future translation to clinical patient populations.
Study Design and Methods This study is an initial pilot trial utilizing a randomized crossover design involving 16 healthy adult participants aged 40 to 85 years with normal respiratory function.
- Screening & Familiarization (Visit 1): Participants undergo baseline screening, including health history reviews and spirometry (pulmonary function testing). They are also familiarized with the testing and training activities.
- Intervention Sessions: Across separate intervention visits separated by a 6-week washout period, participants receive 20 minutes of neck-based tsDCS paired with CST. During active stimulation, current is delivered continuously, whereas sham stimulation provides brief ramping periods without sustained current. CST involves visual feedback on a computer screen to guide participants through coughing at specific target ranges (strong, moderate, and weak).
- Assessments: Researchers record vital signs, breathing tests, airway occlusions (to measure drive to breathe), maximum respiratory pressure tests. Exploratory measures, such as saliva swallowing patterns and how long participants can produce a vowel sound, are also tracked.
Aims:
- Aim 1: Feasibility and acceptability will be evaluated by the participants' ability to complete all training tasks simultaneously with stimulation, scores from the Acceptability of Intervention Measure (AIM), participant ability to blind/detect sham versus active treatment, and perceived exertion, task difficulty, and stimulation intensity ratings.
- Aim 2: Cough and respiratory performance will be measured by the change in cough peak expiratory flow rate (PEFR) from baseline, along with CST performance accuracy, other cough, resting breathing, and respiratory strength parameters.
Tipo de estudio
Tipo de estudio
Inscripción (Estimado)
Inscripción
Fase
Fase
- No aplica
Contactos y Ubicaciones
Estudio Contacto
Estudio Contacto
- Nombre: May Smith-Hublou, PhD, SLP
- Número de teléfono: 352-273-6855
- Correo electrónico: maysmith@ufl.edu
Copia de seguridad de contactos de estudio
- Nombre: Barbara K Smith, PhD, PT
- Número de teléfono: 352-294-5315
Ubicaciones de estudio
-
-
Florida
-
Gainesville, Florida, Estados Unidos, 32610
- University of Florida
-
Contacto:
- May Smith-Hublou, PhD
- Número de teléfono: 352-273-6855
- Correo electrónico: maysmith@ufl.edu
-
Investigador principal:
- May Smith-Hublou, PhD
-
-
Criterios de participación
Criterio de elegibilidad
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- Forced vital capacity (FVC) ≥ 80% predicted based on age/sex
Exclusion Criteria:
- neurological disease
- respiratory disease including acute respiratory infection with cough during past week
- Pregnancy
- metallic implants in the spine
- cardiac pacemaker
- use of sodium channel blockers, calcium channel blockers, and/or NMDA receptor antagonists
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación cruzada
- Enmascaramiento: Único
Número de brazos
Armas e Intervenciones
Grupo de participantes/brazoGrupo de participantes/brazo |
Intervención / TratamientoIntervención / Tratamiento |
|---|---|
|
Comparador falso: Sham Stimulation
Transcutaneous spinal cord stimulation at reduced intensity, lasting 1 minute at the beginning and end of a 20-minute session. |
CST involves visual feedback on a computer screen to guide participants through coughing at specific target ranges (strong, moderate, and weak). Transcutaneous spinal cord stimulation at reduced intensity, lasting 1 minute at the beginning and end of a 20-minute session. |
|
Experimental: Cathodal Stimulation
Transcutaneous spinal cord stimulation at 2mA intensity, for 20 minutes. |
CST involves visual feedback on a computer screen to guide participants through coughing at specific target ranges (strong, moderate, and weak). Transcutaneous spinal cord stimulation at 2mA intensity, for 20 minutes. |
|
Experimental: Anodal Stimulation
Transcutaneous spinal cord stimulation at 2mA intensity, for 20 minutes. |
CST involves visual feedback on a computer screen to guide participants through coughing at specific target ranges (strong, moderate, and weak). Transcutaneous spinal cord stimulation at 2mA intensity, for 20 minutes. |
¿Qué mide el estudio?
Medidas de resultado primarias
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Completion of training tasks with simultaneous stimulation
Periodo de tiempo: During training
|
Measured as percentage of sessions in which both interventions can be completed simultaneously. |
During training
|
|
Peak Cough Flow
Periodo de tiempo: Baseline, immediate post-single-treatment measurement
|
The highest rate of airflow generated during a volitional cough |
Baseline, immediate post-single-treatment measurement
|
Medidas de resultado secundarias
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Acceptability of Intervention Measure (AIM)
Periodo de tiempo: Immediate post-single-treatment measurement
|
Participants will rate favorability of treatment procedures. This scale consists of 4 items rating acceptability using a 1-5 Likert Scale, with a combined total score range of 4-20. A score of 1 represents "completely disagree," and a score of 5 represents "completely agree." Thus, a higher score reflects a more favorable experience. |
Immediate post-single-treatment measurement
|
Otras medidas de resultado
Otras medidas de resultado
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Airway occlusion pressure (P0.1)
Periodo de tiempo: Baseline vs immediate post-single-treatment
|
The change in air pressure at the opening of the airway (mouth and nose) in the first 100 ms of a breath. This estimates neural drive to breathe. |
Baseline vs immediate post-single-treatment
|
Colaboradores e Investigadores
Patrocinador
Patrocinador
Colaboradores
Colaboradores
Investigadores
Investigadores
- Investigador principal: May Smith-Hublou, PhD, University of Florida
Publicaciones y enlaces útiles
Publicaciones Generales
- Nierat MC, Similowski T, Lamy JC. Does trans-spinal direct current stimulation alter phrenic motoneurons and respiratory neuromechanical outputs in humans? A double-blind, sham-controlled, randomized, crossover study. J Neurosci. 2014 Oct 22;34(43):14420-9. doi: 10.1523/JNEUROSCI.1288-14.2014.
- Delucenay-Clarke R, Nierat MC, Frugiere A, Similowski T, Cayetanot F, Bodineau L. Direct current stimulation as a non-invasive therapeutic alternative for treating autonomic or non-autonomic neurological disorders affecting breathing. Clin Auton Res. 2024 Aug;34(4):395-411. doi: 10.1007/s10286-024-01055-y. Epub 2024 Aug 12.
- Clark DJ, Hawkins KA, Winesett SP, Cox BA, Pesquera S, Miles JW, Fuller DD, Fox EJ. Enhancing Locomotor Learning With Transcutaneous Spinal Electrical Stimulation and Somatosensory Augmentation: A Pilot Randomized Controlled Trial in Older Adults. Front Aging Neurosci. 2022 Mar 2;14:837467. doi: 10.3389/fnagi.2022.837467. eCollection 2022.
- Borders JC, Villarreal-Cavazos K, Huber JE, Quinn L, Keller B, Troche MS. Enhancing Cough Motor Learning in Parkinson's Disease Through Variable Practice During Skill Training. Mov Disord Clin Pract. 2024 Dec;11(12):1500-1515. doi: 10.1002/mdc3.14218. Epub 2024 Oct 8.
- Benussi A, Cantoni V, Grassi M, Libri I, Cotelli MS, Tarantino B, Datta A, Thomas C, Huber N, Karkkainen S, Herukka SK, Haapasalo A, Filosto M, Padovani A, Borroni B. Cortico-spinal tDCS in amyotrophic lateral sclerosis: A randomized, double-blind, sham-controlled trial followed by an open-label phase. Brain Stimul. 2023 Nov-Dec;16(6):1666-1676. doi: 10.1016/j.brs.2023.11.008. Epub 2023 Nov 15.
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Estimado)
Inicio del estudio
Finalización primaria (Estimado)
Finalización primaria
Finalización del estudio (Estimado)
Finalización del estudio
Fechas de registro del estudio
Enviado por primera vez
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Publicado por primera vez
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización publicada
Última actualización enviada que cumplió con los criterios de control de calidad
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
Otros números de identificación del estudio
- IRB202600626
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Descripción del plan IPD
Participant data that underlie the results reported in this article after deidentification.
Marco de tiempo para compartir IPD
9 months and ending 36 months following article publication.
Criterios de acceso compartido de IPD
Investigators whose proposed use of the data has been approved by an independent review committee.
Tipo de información de apoyo para compartir IPD
- PROTOCOLO DE ESTUDIO
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
producto fabricado y exportado desde los EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .